Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HB 2158Session 2025-2026

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances.

Printer's No. PN2792

See other bills
under the
same topic PRINTER'S NO. 2792 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.2158 Session of 2026 INTRODUCED BY DAY, KUZMA, PUGH, WALSH, SHAFFER, ZIMMERMAN AND HEFFLEY, JANUARY 23, 2026 REFERRED TO COMMITTEE ON JUDICIARY, JANUARY 26, 2026 AN ACTAmending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for schedules of controlled substances.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. Section 4(1) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, is amended by adding a subclause to read:Section 4. Schedules of Controlled Substances.--The following schedules include the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated.(1) Schedule I--In determining that a substance comes within 12345678910111213141516171819202122 this schedule, the secretary shall find: a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. The following controlled substances are included in this schedule:* * *(ix) Any material, compound, mixture or preparation that contains 7-hydroxymitragynine in a concentration equal to or exceeding 2% of the total alkaloid content or 1 milligram per recommended serving size, or any synthetic, semi-synthetic or chemically manipulated form of mitragynine, 7-hydroxymitragynine, mitragynine pseudoindoxyl or any other synthetic, semi-synthetic or chemically manipulated alkaloid, metabolite, derivative or analogue of the Mitragyna speciosa plant.* * *Section 2. This act shall take effect in 60 days.20260HB2158PN2792 - 2 - 1234567891011121314151617

Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.